Uploads Contact
/
Login Upload

  • Search Results for 'Investigating And Reporting Adverse'

Investigating and Reporting Adverse
Investigating and Reporting Adverse
liane-varnes
Lessons to learn from the reporting of adverse events in RCTs published in four high impact
Lessons to learn from the reporting of adverse events in RCTs published in four high impact
phoebe-click
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
lois-ondreau
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
mitsue-stanley
Adverse Events
Adverse Events
sherrill-nordquist
AE/SAE/EAE Identification and Reporting
AE/SAE/EAE Identification and Reporting
giovanna-bartolotta
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
natalia-silvester
Expedited Adverse Event
Expedited Adverse Event
pasty-toler
SAFETY PRACTICES AND REPORTING IN CLINICAL RESEARCH
SAFETY PRACTICES AND REPORTING IN CLINICAL RESEARCH
min-jolicoeur
Investigating and Reporting Allegations of Misconduct
Investigating and Reporting Allegations of Misconduct
marina-yarberry
Expedited
Expedited
phoebe-click
Capturing and Reporting Adverse Events in Clinical Research
Capturing and Reporting Adverse Events in Clinical Research
pamella-moone
Expedited Reporting Darlene Kitterman,
Expedited Reporting Darlene Kitterman,
jane-oiler
Did that just happen? And
Did that just happen? And
mitsue-stanley
A series of randomised controlled N-of 1 trials in patients
A series of randomised controlled N-of 1 trials in patients
tatyana-admore
A series of randomised controlled N-of 1 trials in patients who have discontinued or are
A series of randomised controlled N-of 1 trials in patients who have discontinued or are
min-jolicoeur
Social Pharmacy and Pharmacovigilance
Social Pharmacy and Pharmacovigilance
debby-jeon
Unanticipated Problems
Unanticipated Problems
briana-ranney
Unanticipated Problems
Unanticipated Problems
pamella-moone
Postmarket monitoring Overview
Postmarket monitoring Overview
conchita-marotz
Critical Thinking about Institutional Disclosure
Critical Thinking about Institutional Disclosure
trish-goza
FDA Final Rule & Revised CTEP Guidelines for Expedited
FDA Final Rule & Revised CTEP Guidelines for Expedited
stefany-barnette
ASTER One Year Later
ASTER One Year Later
luanne-stotts
Office of Research Oversight Reporting: Who, What, When, and Why
Office of Research Oversight Reporting: Who, What, When, and Why
tatiana-dople